189 related articles for article (PubMed ID: 32598758)
1. [Treatment of candidemia caused by Candida albicans and Candida non - albicans in patients with hematological malignancies].
Klyasova GA; Malchikova AO; Tandilova KS; Blohina EV; Parovichnikova EN; Kravchenko SK; Savchenko VG
Ter Arkh; 2019 Aug; 91(8):84-92. PubMed ID: 32598758
[TBL] [Abstract][Full Text] [Related]
2. [Results of treatment for candidemia in patients with blood system tumors].
Kliasova GA; Blokhina EV; Gracheva AN; Kravchenko SK; Parovichnikova EN; Galstian GM
Ter Arkh; 2013; 85(11):47-53. PubMed ID: 24432599
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological and mycological characteristics of candidemia in patients with hematological malignancies attending a tertiary-care center in India.
Dewan E; Biswas D; Kakati B; Verma SK; Kotwal A; Oberoi A
Hematol Oncol Stem Cell Ther; 2015 Sep; 8(3):99-105. PubMed ID: 26173033
[TBL] [Abstract][Full Text] [Related]
4. [Factors influencing recovery in patients with hemoblastoses and candidemia].
Klyasova GA; Blokhina EV; Gracheva AN; Kravchenko SK; Parovichnikova EN; Okhmat VA; Korobova AG; Galstyan GM; Kulikov SM
Ter Arkh; 2015; 87(7):77-87. PubMed ID: 26390729
[TBL] [Abstract][Full Text] [Related]
5. [Candidemia in an intensive care unit].
Adukauskiene D; Kinderyte A; Dambrauskiene A; Vitkauskiene A
Medicina (Kaunas); 2009; 45(5):351-6. PubMed ID: 19535880
[TBL] [Abstract][Full Text] [Related]
6. Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes.
Pagano L; Antinori A; Ammassari A; Mele L; Nosari A; Melillo L; Martino B; Sanguinetti M; Equitani F; Nobile F; Carotenuto M; Morra E; Morace G; Leone G
Eur J Haematol; 1999 Aug; 63(2):77-85. PubMed ID: 10480286
[TBL] [Abstract][Full Text] [Related]
7. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
8. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome.
Chi HW; Yang YS; Shang ST; Chen KH; Yeh KM; Chang FY; Lin JC
J Microbiol Immunol Infect; 2011 Oct; 44(5):369-75. PubMed ID: 21524971
[TBL] [Abstract][Full Text] [Related]
9. Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes.
Tsai MH; Hsu JF; Yang LY; Pan YB; Lai MY; Chu SM; Huang HR; Chiang MC; Fu RH; Lu JJ
Sci Rep; 2018 Oct; 8(1):15239. PubMed ID: 30323257
[TBL] [Abstract][Full Text] [Related]
10. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade.
Parmeland L; Gazon M; Guerin C; Argaud L; Lehot JJ; Bastien O; Allaouchiche B; Michallet M; Picot S; Bienvenu AL;
Med Mycol; 2013 Jan; 51(1):33-7. PubMed ID: 22680978
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial Bloodstream Infection Due to Candida spp. in China: Species Distribution, Clinical Features, and Outcomes.
Li Y; Du M; Chen LA; Liu Y; Liang Z
Mycopathologia; 2016 Aug; 181(7-8):485-95. PubMed ID: 26994763
[TBL] [Abstract][Full Text] [Related]
12. [Candidemia in Cancer Patients: Focus Mainly on Hematological Malignancyand Hematopoietic Stem Cell Transplantation].
Okinaka K
Med Mycol J; 2016; 57(3):J117-23. PubMed ID: 27581780
[TBL] [Abstract][Full Text] [Related]
13. A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies.
Gamaletsou MN; Walsh TJ; Zaoutis T; Pagoni M; Kotsopoulou M; Voulgarelis M; Panayiotidis P; Vassilakopoulos T; Angelopoulou MK; Marangos M; Spyridonidis A; Kofteridis D; Pouli A; Sotiropoulos D; Matsouka P; Argyropoulou A; Perloretzou S; Leckerman K; Manaka A; Oikonomopoulos P; Daikos G; Petrikkos G; Sipsas NV
Clin Microbiol Infect; 2014 Jan; 20(1):O50-7. PubMed ID: 23889746
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology, risk factors and outcomes of
Zhang W; Song X; Wu H; Zheng R
Epidemiol Infect; 2019 Sep; 147():e277. PubMed ID: 31552814
[TBL] [Abstract][Full Text] [Related]
15. The risk and clinical outcome of candidemia depending on underlying malignancy.
Lortholary O; Renaudat C; Sitbon K; Desnos-Ollivier M; Bretagne S; Dromer F;
Intensive Care Med; 2017 May; 43(5):652-662. PubMed ID: 28321466
[TBL] [Abstract][Full Text] [Related]
16. Candida guilliermondii Complex Is Characterized by High Antifungal Resistance but Low Mortality in 22 Cases of Candidemia.
Marcos-Zambrano LJ; Puig-Asensio M; Pérez-García F; Escribano P; Sánchez-Carrillo C; Zaragoza O; Padilla B; Cuenca-Estrella M; Almirante B; Martín-Gómez MT; Muñoz P; Bouza E; Guinea J
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28438935
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.
Cornely OA; Vazquez J; De Waele J; Betts R; Rotstein C; Nucci M; Pappas PG; Ullmann AJ
Mycoses; 2014 Feb; 57(2):79-89. PubMed ID: 23786573
[TBL] [Abstract][Full Text] [Related]
18. Invasive candidiasis in cancer patients: observations from a randomized clinical trial.
DiNubile MJ; Hille D; Sable CA; Kartsonis NA
J Infect; 2005 Jun; 50(5):443-9. PubMed ID: 15907554
[TBL] [Abstract][Full Text] [Related]
19. Candidemia in Adults at a Tertiary Hospital in China: Clinical Characteristics, Species Distribution, Resistance, and Outcomes.
Lin S; Chen R; Zhu S; Wang H; Wang L; Zou J; Yan J; Zhang X; Farmakiotis D; Tan X; Mylonakis E
Mycopathologia; 2018 Aug; 183(4):679-689. PubMed ID: 29572768
[TBL] [Abstract][Full Text] [Related]
20. Factors and outcomes associated with candidemia caused by non-albicans Candida spp versus Candida albicans in children.
Lee WJ; Hsu JF; Lai MY; Chiang MC; Lin HC; Huang HR; Wu IH; Chu SM; Fu RH; Tsai MH
Am J Infect Control; 2018 Dec; 46(12):1387-1393. PubMed ID: 30100260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
